| Literature DB >> 26635777 |
Loh Teng-Hern Tan1, Hooi-Leng Ser1, Wai-Fong Yin2, Kok-Gan Chan2, Learn-Han Lee1, Bey-Hing Goh1.
Abstract
A Streptomyces strain, MUM256 was isolated from Tanjung Lumpur mangrove soil in Malaysia. Characterization of the strain showed that it has properties consistent with those of the members of the genus Streptomyces. In order to explore the potential bioactivities, extract of the fermented broth culture of MUM256 was prepared with organic solvent extraction method. DPPH and SOD activity were utilized to examine the antioxidant capacity and the results have revealed the potency of MUM256 in superoxide anion scavenging activity in dose-dependent manner. The cytotoxicity of MUM256 extract was determined using cell viability assay against 8 different panels of human cancer cell lines. Among all the tested cancer cells, HCT116 was the most sensitive toward the extract treatment. At the highest concentration of tested extract, the result showed 2.3-, 2.0-, and 1.8-folds higher inhibitory effect against HCT116, HT29, and Caco-2 respectively when compared to normal cell line. This result has demonstrated that MUM256 extract was selectively cytotoxic toward colon cancer cell lines. In order to determine the constituents responsible for its bioactivities, the extract was then subjected to chemical analysis using GC-MS. The analysis resulted in the identification of chemical constituents including phenolic and pyrrolopyrazine compounds which may responsible for antioxidant and anticancer activities observed. Based on the findings of this study, the presence of bioactive constituents in MUM256 extract could be a potential source for the development of antioxidative and chemopreventive agents.Entities:
Keywords: Malaysia; Streptomyces sp.; anticancer; antioxidant; mangrove
Year: 2015 PMID: 26635777 PMCID: PMC4659911 DOI: 10.3389/fmicb.2015.01316
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Figure 1Neighbor-joining phylogenetic tree based on 1487 nucleotides of 16S rRNA gene sequence showing the relationship between strain MUSC 149. Numbers at nodes indicate percentages of 1000 bootstrap re-samplings, only values above 50% are shown. Bar, 0.001 substitutions per site. Asterisks indicate that the corresponding nodes were also recovered using the maximum-likelihood tree-making algorithm.
The antioxidant activities demonstrated by MUM256 extract in both DPPH assay and SOD activity assay.
| 125 | ND | 16.33 ± 2.89 |
| 250 | ND | 21.35 ± 2.41 |
| 500 | ND | 31.56 ± 4.25 |
| 1000 | ND | 46.45 ± 5.72 |
| 2000 | 6.69 ± 0.83 | 67.25 ± 8.82 |
| 4000 | 12.08 ± 1.05 | NT |
ND, not detected; NT, not tested.
Figure 2Anticancer activity of MUM256 extract against human cancer cell lines. The anticancer activity of streptomyces sp. Mum256 extract against all the cancer cell lines measured using mtt assay. Each bar represents the mean of the cell viability of the cell lines after treatment with extract at respective concentrations tested (n = 5). The vertical lines associated with the bars represent the standard deviation of the mean. Symbol (*) indicates p < 0.05 significant difference compared to control.
Figure 3Comparison of the percentage of inhibition exerted by the extract at respective concentrations between normal cell line (BEAS-2B) and colon cancer cell lines [HCT116 (A), HT29 (B), and Caco-2 (C)]. Selective cytotoxicity index determined for the extract against the colon cancer cells (D). Each bar represents the mean of inhibition (%) of the extract at respective concentrations tested (n = 5) against respective cell lines. The vertical lines associated with the bars represent the standard deviation of the mean. Symbol (*) indicates p < 0.05 significant difference between the normal cell line and the colon cancer cell line.
Figure 4Morphology of HCT116 after treatment with MUM256 extract at different concentrations. Comparison of the morphological features of HCT116 after the 72 h with MUM256 extract at respective concentrations [control (A), 100 μg/mL (B), 200 μg/mL (C), 400 μg/mL (D)] observed under an inverted microscope with objective lens x40. Arrow indicates the abnormal morphological features resulted from the anticancer effect of MUM256 extract.
Chemical constituents identified in of .
| 1 | Phenol,2,4-bis(1,1-dimethylethyl)- | Phenolic compound | 44.445 | C14H22O | 206 | 96 | Narendhran et al., |
| 2 | Pyrrolo[1,2a]pyrazine-1,4-dione,hexahydro- | Pyrrolopyrazine | 53.297 | C7H10N2O2 | 154 | 98 | Narasaiah et al., |
| 3 | Pyrrolo[1,2a]pyrazine-1,4-dione,hexahydro-3-(2-methylpropyl)- | Pyrrolopyrazine | 58.510 | C11H18N2O2 | 210 | 64 | Narasaiah et al., |
| 4 | 9 | β-carboline alkaloid | 60.381 | C11H8N2 | 168 | 96 | Zheng et al., |
| 5 | Pyrrolo[1,2-a]pyrazine-1,4-dione,hexahydro-3-(phenylmethyl)- | Pyrrolopyrazine | 72.071 | C14H16N2O2 | 244 | 97 | Narasaiah et al., |
| 6 | Phenol,2,2′-methylenebis[6-(1,1-dimethylethyl)-4-methyl- | Phenolic compound | 73.507 | C23H32O2 | 340 | 96 | Narendhran et al., |
| 7 | 1,2-Benzenedicarboxylic acid, mono(2-ethylhexyl) ester | Dicarboxylic acid ester | 76.883 | C16H22O4 | 278 | 91 | Krishnan et al., |
Figure 5Chemical structures of constituents detected in MUM256 extract.